Other Events ·
PetVivo Holdings, Inc. entered into a Termination and Settlement Agreement with VetStem, Inc., effective July 24…
PETVPetVivo Holdings, Inc.
PetVivo Holdings, Inc. entered into a Termination and Settlement Agreement with VetStem, Inc., effective July 24, 2026, to terminate their Exclusive License and Supply Agreement for the PrecisePRP® product line. The parties mutually released all claims and extinguished outstanding financial obligations, including invoices and royalties. PetVivo’s sole remaining obligation is an aggregate cash payment of $75,000, split into a $50,000 payment within 14 days and a $25,000 payment within 30 business days. Remaining PrecisePRP® inventory transfers to VetStem, subject to reconciliation if quantities fall below agreed minimums. The warrant held by VetStem for 250,000 shares remains outstanding. PetVivo Holdings operates in the biomedical device industry, manufacturing and commercializing medical devices and therapeutics for companion animals.